G
Grifols SA
GRFS
7.64000
USD
0.165
(2.21%)
مفتوح الان
حجم التداول
8,529
الربح لكل سهم
0
العائد الربحي
0
P/E
33
حجم السوق
5,885,588,863
الأخبار
العنوان: Grifols SA
القطاع: Healthcare
الصناعة: Drug Manufacturers - General
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.